420 with CNW – Louisiana Assembly OKs Medical Marijuana for Debilitating Conditions

On Friday, the Louisiana House of Representatives overwhelmingly approved bills that would significantly expand the state’s medical cannabis program. Residents suffering from debilitating conditions, especially those who cannot access medical marijuana, will now be happy to know that the medical marijuana program will have its list of qualifying conditions expanded to fit a wider range of ailments. Dispensaries will also be allowed to deliver marijuana products directly to the patients’ homes.

Both bills were sponsored by Rep. Larry Bagley, with his medical condition expansion bill passed 76-15 and the delivery bill was approved 80-15. This comes a week after a Louisiana House Committee approved both bills as well as several other cannabis expansion bills and sent them to the full House for debate. In a broad sense, the expansion bill will permit doctors to issue recommendations for any debilitating condition instead of the short list of conditions that is currently allowed by law.

When it was originally drafted, the expansion legislation would have simply added traumatic brain injury and concussions to the list of qualifying conditions. However, it was amended in the committee to add several other conditions and language that states cannabis can be recommended for any condition that a doctor “considers debilitating to an individual patient.” Currently, Louisiana has a list of 14 conditions including cancer, epilepsy, severe muscle spasms and Parkinson’s disease that qualify one for a medical marijuana prescription.

“I’ll say this, I have never been a proponent of medical marijuana. I voted against every piece of legislation that came down because I just didn’t believe in it and I thought there was an ulterior motive. But now, constituents in my area, they come to me and they ask me for help because they’re having pain, they can’t find things to cure the pain. They’re using opioids, some of them, they’ve got problems that the doctors can’t seem to help. So this is just another avenue. Now their personal physician can write them a prescription for cannabis and they can get it. Who knows you better than your personal physician? I thought it made perfect sense,” says bill sponsor Bagley.

The cannabis delivery bill, on the other hand, would require the government to establish “procedures and regulations relative to delivery of dispensed marijuana to patients by designated employees or agents of the pharmacy.” Both bills now head to the State Senate for consideration.

Analysts believe that industry players like The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) are hoping that the state senate thinks about the plight of patients with debilitating conditions and approves the two bills.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Cannabis Could Prevent Coronavirus Infection, Canadian Study Finds

A little over four months after the coronavirus was first identified in Wuhan, China, the virus has infected over 4.5 million people worldwide and left at least 300,000 dead, and the hunt for a cure and ultimately a vaccine is raging on. However, due to insufficient data on the novel coronavirus and its penchant towards mutation, scientists are basically shooting in the dark and hoping for a favorable outcome. There have been rumors of numerous cures for the virus, from the anti-malaria drug hydrochxychloroquine, herbal cures and coronavirus oils to cannabis, all of which have been dismissed.

However, based on the results from a preliminary study, proponents of cannabis as a cure or means of prevention against the coronavirus shouldn’t give up just yet. Scientists conducting a study at Canada’s University of Lethbridge are now theorizing that certain strains of cannabis may possibly prevent COVID-19 infection. After studying over 400 strains of marijuana, the researchers concluded that at least a dozen of them helped in preventing the coronavirus from having a host in the mouth, intestines and lungs.

According to the study’s head researcher Dr. Igor Kovalchuck, “a number of them have reduced the number of the virus receptors by 73%, and the chances of it getting in is much lower. If they can reduce the number of receptors, there’s much less chance of getting infected.” The study, which was published April 19 on Preprints, a platform of early versions of research outputs, states that all cannabis plants for the study were grown in a licensed facility at the University of Lethbridge to obtain the extracts, which were then applied to artificial human 3D tissue models of oral, airway and intestinal tissues.

The researchers identified 13 CBD extracts that are able to change the levels of enzyme ACE2 which has previously been linked to COVID-19 infection. Some strains were also found to control serine protease TMPRSS2, another protein that facilitates the infection of COVID-19 into host cells. The study concluded that the extracts, “pending further investigation, may become a useful and safe addition to the treatment of COVID-19 as an adjunct therapy.”

Once the study is peer reviewed and more research proves cannabis’ viability in preventing coronavirus infection, “the extracts can be used to develop easy to use preventative treatments in the form of mouthwash and throat gargle products for both clinical and at-home use. Such products ought to be tested for their potential to decrease viral entry via the oral mucosa. Given the current dire and rapidly evolving epidemiological situation, every possible therapeutic opportunity and avenue must be considered.”

Industry watchers say such research findings come as good news to marijuana companies like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) who have always said that the full medical benefits of this versatile plant will takes years or even decades to be fully documented.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Obtains Initial Order Granting CCAA Protection

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced that it and certain of its direct and indirect wholly owned subsidiaries (collectively  the “company” or the “applicants”) have filed for insolvency protection under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”). The company has obtained an order from the Ontario Superior Court of Justice granting the applicants protection under the CCAA. Ernst & Young Inc. (“E&Y”) has consented to act as the court-appointed monitor of the applicants. The court has granted CCAA protection for an initial 10 day period, which expires on May 29, 2020, and is subject to extension thereafter as the court deems appropriate. Creditors and others are stayed from enforcing any rights against the applicants while under CCAA protection.

To view the full press release, visit http://cnw.fm/4UrG6

About Green Growth Brands Inc.

Green Growth Brands creates remarkable experiences in cannabis. The company’s brands include CAMP, The+Source, and 8 Fold. GGB is expanding its cannabis operations throughout the U.S., via dispensaries in Nevada, Massachusetts and Florida. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGB

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

HempNewsBreaks – Marijuana Company of America, Inc. (MCOA) Reports Increased Revenues, Positive Financial Developments for Year-Ended December 31, 2019

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, today released audited financial results for the year ended December 31, 2019, as included in its annual report on Form 10-K. Among the notable highlights, the company reported a significant 175.7% year-over-year increase in total revenues to $695,076 for the year ended December 31, 2019, as compared to $252,135 for the year ended December 31, 2018. “Our financial results reflect a transition as our company converts from a Research and Development company to a marketing-product based company,” MCOA chief executive officer Jesus Quintero stated in the news release. “Our financial losses reflect our commitment to terminate non-profitable relationships and investments which have resulted in diminishing cashflows. MCOA, through its hempSMART brand, has experienced a dramatic increase in sales and gross profits during 2019.  As we move forward in 2020, our commitment is to improve shareholder’ values through increased sales, steady profitability and expense reductions throughout 2020.”

To view the full press release, visit http://cnw.fm/Pc1Vw

About Marijuana Company of America Inc.

MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART(TM), which targets general health and well-being; (2) an affiliate marketing and retail sales program to promote and sell its legal hemp-based consumer products containing CBD; (3) joint ventures and acquisitions of business entities engaged in the growth and sale of hemp and cannabis products in jurisdictions where cultivation is legal; and (4) the expansion of its business into ancillary areas as market opportunities in this segment mature and develop. For more information, visit www.MarijuanaCompanyofAmerica.com.

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://cnw.fm/MCOA

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Pending Merger Partner Enters LOI to Acquire Five Leaf Labs

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, on Tuesday announced that one of its two pending merger partners, Cannaworx, Inc., is substantially expanding its sales and distribution network through a letter of intent (“LOI”) to acquire Louisiana-based Five Leaf Labs (“FLL”). FLL recently released its first set of CBD-infused products to the U.S. market. “We attribute the success of our initial launch to both the high quality of our hemp source supply and processing methods, and to the effectiveness of our well-trained, knowledgeable and experienced network of over 50 sales representatives spanning 21 states,” Five Leaf Laboratories founder and president Keyon Janani stated in the news release. Cannaworx and its principals have twelve products being prepared for market launch over the next year, including two novel products that employ the company’s patented/patent pending, full and partial spectrum, hemp-derived phytocannabinoid formulations for pain relief. This acquisition is critically timed for Cannaworx, as it is anticipating the market launch of its first two products over the coming weeks. “From the day we met Keyon, we have been thoroughly impressed with him, the rest of the FLL team, their innovative product line, and of course their very strong and capable sales and distribution network. In addition, we are also motivated by the compelling standards of quality that drive Keyon and his team. For example, every product batch at FLL goes through rigorous third-party review and certification for content, consistency, and potency, from one of the most respected academic institutions in the U.S. We are pleased to be adding Five Leaf Laboratories to the Cannaworx family,” Cannaworx co-founder and president Dr. Bobby Ghalili stated in the news release.

To view the full press release, visit http://cnw.fm/Jir83

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life-sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure-cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the biopharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and (ii) prepare higher-quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW – California Governor Delays Implementation of Proposed Marijuana Regulatory Changes

Although most states designated the cannabis industry as essential and allowed businesses to keep operating despite the lockdown, the industry as a whole has suffered a variety of setbacks due to the coronavirus pandemic. A number of campaigns to legalize marijuana have been put on hold all over the country due to social distancing measures. In California, lawmakers have been forced to postpone systemic reforms to the California regulatory agencies that oversee the state’s marijuana industry.

When he announced his annual budget plan earlier this year, California Governor Gavin Newsom revealed that he wanted to; merge the trio of regulatory agencies, the Bureau of Cannabis Control, [BCC], the Department of Food and Agriculture and the Department of Public Health into a single Department of Cannabis Control [DCC] and streamline cannabis tax collections by July 2021. The BCC has oversight over retailers, delivery services, micro businesses, distributors, testing labs, cannabis events while the Department of Public Health regulates marijuana manufactures and the Department of Food and Agriculture oversees growers.

Cannabis businesses, especially vertically integrated firms with licenses from more than one agency, had been receiving conflicting messages from state authorities, and a single regulatory agency would mitigate that. The revamped tax collection, on the other hand, would have made tax collection easier for the state. However, due to complications stemming from the coronavirus, the plan will have to be put on hold until next year. According to the newly revised budget summary, Governor Newsom’s plans won’t happen until 2021 at the earliest.

The revised budget summary states that his administration was “in the process of developing a more detailed plan for the transition from three agencies to one. However, the process was interrupted by the COVID-19 pandemic, requiring a delay in the consolidation as planned.” It adds that Gov. Newsom’s administration remains committed to simplifying and improving cannabis tax administration through a proposal for inclusion in the budget next year. According to the summary, a consolidation plan will be included in the 2021-2022 budget.

Additionally, the revised budget summary stipulates that marijuana regulators will receive $143.8 in funding, with the BCC receiving $68.2 million, the Department of Public Health receiving $20.8million and the Department of Food and Agriculture receiving $54.8 million. The money will be used to fund ongoing licensing and enforcement by the three agencies and to “shift sworn investigators from the Department of Consumer Affairs [DCA] to the Bureau of Cannabis Control,” a wing of the DCA.

It isn’t clear what participants in the industry, such as Round Meadow Holdings Corp. and Sugarmade Inc. (OTCQB: SGMD), think about the implications of this delay on the operations of cannabis businesses in California.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Congress Passes Coronavirus Bill With Marijuana Banking Provisions

Although government-issued coronavirus-related measures were designed to curb the spread of the virus, they had an unintended consequence, economic downturn. With all but the most essential businesses ordered to close during lock-downs, the economy was in a free fall. More than 20 million Americans have lost their jobs since the start of March, and the government ended up deploying a massive $2 trillion coronavirus relief bill to help people and small businesses weather the storm.

However, due to ongoing federal prohibition, businesses in the state-legal marijuana industry were denied access to these relief funds. Federal prohibition has made banking institutions avoid cannabis businesses, dooming them to cash only transactions which in current times are a big no. Advocates, stakeholders and lawmakers decried the cannabis industry’s exclusion from these funds, stating that it pays taxes just like any other business and many small businesses in the sector are facing financial hardship due to the coronavirus pandemic.

On May 15, the U.S. House of Representatives passed a $3 trillion coronavirus stimulus bill which includes a provision that would allow banks to serve state-legal marijuana businesses without fear of federal retaliation. Dubbed “The Health and Economic Recovery Omnibus Solutions [HEROES] Act,” the bill includes the SAFE Banking Act which granted banks permission to transact with cannabis businesses without fear of federal reprisal. It was approved by the House last fall but has since been stuck in a Senate Committee.

“The inclusion of cannabis banking in the HEROES Act is a positive statement from the House and strongly supplements the decision that the majority of states have made by designating cannabis businesses as essential.” says Washington DC lobbyist David Mangone who lobbies for the National Cannabis Roundtable. Cannabis was one of the few industries that were designated as essential by state governments. However, since marijuana businesses do not have access to cashless payment systems, they have to transact on a cash only basis, greatly increasing the workers’ and customers risk of infection.

“The pathway forward in the Senate is both uncertain and challenging, but SAFE banking is one of the few provisions that not only has strong bipartisan support but also generates revenue rather than adds to the deficit,” Mangone says.

The bill now heads to the Senate which has never passed cannabis banking legislation and has already shown some push back. “I would be surprised if it passed the Senate, just given Senate Majority Leader Mitch McConnell’s comments on the SAFE Act previously, and given his statements about his reaction to it in the last 24 hours,” says Jonathan Havens, co-chair of the Cannabis Law Practice.

“It’s not enough that the House is going to do this. The Senate really needs to act in concert, and it doesn’t sound like they are going to do that if you take your cues from McConnell.”

Cannabis industry watchers say sector players like SinglePoint Inc. (OTCQB: SING) must be wondering what it will take for the Senate to consider the issue of cannabis banking objectively and pass the pending bills before them.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) CEO Featured in The Stock Day Podcast with Everett Jolly

Cannabis Global (OTC: MCTC), a Nevada registered, fully reporting and audited publicly-traded company, today announced that its CEO, Arman Tabatabaei, was featured on The Stock Day Podcast hosted by Everett Jolly. During the interview, Tabatabaei discussed Cannabis Global’s IP strategy and extensive portfolio. “The roots of our company is our intellectual property,” Tabatabaei said in the interview. “The overall strategy has been to develop the intellectual property first and then move towards building products around that intellectual property, and finally to engage in some vertical integration. We have now filed six provisional patents. Simply put, the intellectual property centers on better ways to integrate cannabinoids into foods and beverages,” he explained, adding that the Company strives to design chemical-free fusion technologies.

To view the full press release, visit http://cnw.fm/GPLn7

About Cannabis Global, Inc.

Cannabis Global, Inc. (MCTC) is a Nevada registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. More information on the Company can be viewed at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

How COVID-19 Has Drastically Changed U.S Cannabis Smoking Pattern

The coronavirus pandemic started in Wuhan, China last December 2019. It happened so fast that we barely even realized we’re already 5 months in lockdown.

The impact of coronavirus has a way of affecting not just the economy but our personality as well. Behavioral science and the history of previous global pandemics even suggest that COVID-19 will transform our perception in life forever.

To understand the impact deeper, AmericanMarijuana.org conducted a survey involving 1,017 American cannabis consumers asking how COVID-19 changed their weed-smoking habits and how their families and friends feel about their habit these days.

Does Smoking Make Weed-Smokers Susceptible to Coronavirus?

The act of smoking means fingers are constantly in contact with the lips, thus increasing the risks of transmitting the virus, according to the World Health Organization.

The participants were divided into 2 categories: those with lung problems and those without lung problems. Of the 1,017 participants that took the survey, 873 (85.5%) said they don’t have any lung problems while 144 (14%) revealed they do have lung problems.

According to 301 (34.47%) of participants without lung problems and 78 (54.35%) of participants with lung problems, they agree that smoking weed will make them more susceptible to coronavirus.

Whereas 48 (5.53%) of participants without lung problems and 66 (45.65%) of participants with lung problems have similar opinions and don’t agree that weed-smoking puts them at risk of catching coronavirus.

Sharing Behaviors of Marijuana Tools, Utensils, and Accessories Amidst COVID-19 Outbreak

The participants were also asked if they kept sharing marijuana tools, utensils, and accessories since the coronavirus outbreak.

According to 288 (28.35%) of the participants, they still share even after the global pandemic outbreak. The remaining 71.65% stopped sharing joints, bongs, bowls, pipes, spliffs, vape pens, and similar items.

Why do You Continue to Share? What’s Your Motive?

The participants were then asked why they continue to share.

And according to 86 (29.89%) out of the 288 participants that still share (marijuana tools, utensils, and accessories), they do so because they don’t see any reason why they should stop sharing them. 100 (38.04%) of them continue to share because they can’t get rid of the habit.

92 (32.07%) of them share because they just want to have fun with friends and to also relieve some stress.

Participants that stopped sharing marijuana tools, utensils, and accessories were also asked why of their motive on why they do so.

114 (15.70%) stopped to lower the risk of getting infected with coronavirus through these items while 155 (21.29%) do so to practice social distancing.

459 or (63.01%) of them stopped to practice both social distancing and to avoid the risk of getting infected with the virus.

What About Your Friends? Do they Still Share their Weed with You?

Getting infected with coronavirus via sharing marijuana tools and accessories is high. While it’s true that you can do something to keep yourself safe, keeping your friends in control is a different story.

This is true to 333 (34.82%) of the participants that still have stoner friends who share weed with them since the coronavirus outbreak.

But weed buddies of the remaining 663 (65.18%) survey participants have already stopped sharing weed with them to limit the spreading of the virus.

Do you Smoke More or Less Weed Now?

People have consumed more food and used up more hand sanitizers, alcohol, and toilet paper since lockdown was implemented worldwide. But aside from the obvious essentials, American people are also stocking up on cannabis.

Does this mean American pot smokers are also smoking more than their usual dosage? Not likely…

You see, only 298 (29.28%) of them have smoked more since the COVID-19 outbreak and only 270 (26.5%) have smoked less. The majority of the participants or 392 (38.52%) of them smoked the same amount of weed even after the outbreak.

Surprisingly enough, 58 (5.7%) of the survey takers quit smoking weed since the coronavirus outbreak.

Have You Considered Switching to Other Marijuana Consuming Methods?

Marijuana can be inhaled, smoked, or consumed orally, depending on the type of product. Moreover, it can also be consumed via hand pipes, water pipes, rolling papers, tinctures, vaporizers, and the list goes on.

According to 285 (28.04%) of American marijuana smokers, they did try to switch to other marijuana consuming methods such as eating edibles, consuming oils, and others. The remaining 732 (71.96%) of them didn’t bother changing at all.

What About Anxiety Relief Supplements?

Keeping ourselves calm amidst this global pandemic is vital. This goes true to 351 (34.51%) of the survey participants that took anxiety relief supplements.

But only 29 (8.32%) said weed is less effective when it comes to keeping them calm amidst the global pandemic compared to 92 (26.19%) of them that claimed weed is the more effective.

666 (65.49%) of the survey participants are satisfied with weed that they haven’t used any anxiety relief supplements since the global pandemic outbreak.

Fear of Not Being Able to Pay for Cannabis

Similar to the fear of not being able to pay for food, hand sanitizers, alcohols, and toilet papers, are weed smokers also afraid of not being able to pay for cannabis products?

Of the 1,017 participants, only 373 (36.67%) are worried compared to 644 (63.33%) that aren’t worried at all.

Friends and Family Member’s Reactions to Weed Smoking Activities

Friends and families of survey participants have to deal with their weed-smoking habits at home. So, how did they feel about it?

Friends and families of the 135 (13.25%) survey participants were against their weed-smoking habits during the pandemic compared to family members and friends of the 704 (69.18%) survey participants that felt nothing has changed.

138 (13.56%) of the survey participants had seen negative attitudes from family members and friends, but not seriously, whereas family members and friends of 41 (4.01%) survey participants shown discrimination for smoking weed during the pandemic.

– This article was provided by Dwight K. Blake, Editor in Chief of AmericanMarijuana.org

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

This article contains Third-Party Content submitted by third parties, including articles submitted through the CNW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of CNW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and CNW does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by CNW providing you with this internet portal that makes accessible to you the ability to view third-party content through the CNW site, CNW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. CNW expressly disclaims liability relating to such third-party content. CNW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, CNW reserves the right to remove third-party content at any time in its sole discretion.

CannabisNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Announces Update on May Debentures

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced that an event of default has occurred in respect of its US$45.5 million principal amount of 15.00% secured convertible debentures, which matured on May 17, 2020.  As previously disclosed, Green Growth Brands received, on May 5, 2020, US$400,000 of debt financing from All Js Greenspace LLC (“All Js’) on a secured basis. On May 12, 2020, All Js’ advanced, also on a secured basis, an additional US$400,000 to the company.

To view the full press release, visit http://cnw.fm/oX6Vi

About Green Growth Brands Inc.

Green Growth Brands creates remarkable experiences in cannabis. The company’s brands include CAMP, The+Source, and 8 Fold. GGB is expanding its cannabis operations throughout the U.S., via dispensaries in Nevada, Massachusetts and Florida. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGB

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com